VERTEX PHARMACEUTICALS (EUROPE) LIMITED NUF

LONDON W2 6BD

Finances

Share Ownership

Return on Equity

28,05 %

Current Ratio

1,8

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	9 090 000	7 901 000	8 662 000	3 526 000
Net Income	481 000	383 000	461 000	224 000
Total Assets	3 729 000	3 461 000	3 208 000	1 395 000
Total Equity	1 715 000	1 234 000	852 000	391 000

Income (NOK)	2022	2021	2020	2019
Revenue	9 090 000	7 901 000	8 662 000	3 526 000
Expenditure	8 456 000	7 349 000	8 057 000	3 280 000
Operating Profit	634 000	551 000	604 000	246 000
Financial Income	0	3 000	39 000	0
Financial Costs	0	0	0	2 000
Financial Balance	0	3 000	39 000	−2 000
Earnings Before Tax	634 000	554 000	644 000	244 000
Tax	153 000	171 000	183 000	21 000
Net Income	481 000	383 000	461 000	224 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	107 000	3 461 000	17 000	0
Total Current Assets	3 622 000	0	3 191 000	1 395 000
Total Assets	3 729 000	3 461 000	3 208 000	1 395 000
Total Retained Equity	0	0	0	391 000
Total Equity	1 715 000	1 234 000	852 000	391 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	2 014 000	2 227 000	2 356 000	1 004 000
Total Equity and Debt	3 729 000	3 461 000	3 208 000	1 395 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	8 662 000	0
Other Income	9 090 000	7 901 000	0	3 526 000
Revenue	9 090 000	7 901 000	8 662 000	3 526 000
Cost of Goods Sold	0	0	0	0
Salary Costs	4 901 000	4 170 000	3 210 000	314 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	8 456 000	7 349 000	8 057 000	3 280 000
Operating Profit	634 000	551 000	604 000	246 000
Financial Income	0	3 000	39 000	0
Financial Costs	0	0	0	2 000
Financial Balance	0	3 000	39 000	−2 000
Dividends	0	0	0	0
Net Income	481 000	383 000	461 000	224 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	107 000	89 000	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	17 000	0
Total Tangible Assets	0	0	17 000	0
Total Fiancial Fixed Assets	0	3 372 000	0	0
Total Fixed Assets	107 000	3 461 000	17 000	0
Stock	0	0	0	0
Total Investments	0	0	2 076 000	0
Cash, Bank	3 306 000	0	1 115 000	1 395 000
Total Current Assets	3 622 000	0	3 191 000	1 395 000
Total Assets	3 729 000	3 461 000	3 208 000	1 395 000
Total Equity	1 715 000	1 234 000	852 000	391 000
Short-Term Group Debt	301 000	405 000	115 000	15 000
Total Long-Term Debt	0	0	0	0
Creditors	122 000	0	0	369 000
Unpaid Taxes	0	214 000	0	0
Dividends	0	0	0	0
Other Current Debt	1 210 000	1 196 000	1 843 000	477 000
Total Current Debt	2 014 000	2 227 000	2 356 000	1 004 000
Total Equity and Debt	3 729 000	3 461 000	3 208 000	1 395 000

Financial indicators	2022	2021	2020	2019
Return on Equity	28,05 %	31,04 %	54,11 %	57,29 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	6,97 %	6,97 %	6,97 %	6,98 %
Current Ratio	1,8	0	1,35	1,39
Quick Ratio	1,8	0	1,35	1,39
Equity Ratio	0,46	0,36	0,27	0,28
Gross Profit Margin	100 %	100 %	100 %	100 %

Rotate your device to see the full table